Feb 1, 2020 | EAS in Action, EASeNews, Medical Devices
Device companies seeking to develop products that include a mobile app must ensure regulatory compliance with product and data safety.
Feb 1, 2020 | EASeNews, Issue of the Month
By Radhika Rajagopalan The FDA Generic Drug User Fees Amendment (GDUFA) has entered a relatively matured stage with applicants of Abbreviated New Drug Applications (ANDAs) experiencing a timely review and communications regarding their submissions packet, as well as...
Feb 1, 2020 | Who’s Who at EAS
Garth Kahl has a long career history working with organic crop and livestock farms and processing throughout the U.S. and Latin America to ensure compliance under NOP, EC 834/2007, Mexico LPO, COR and JAS standards. He assists EAS clients with all aspects of organic...
Feb 1, 2020 | Dietary Supplements, EAS in Action, EASeNews
Supplement brands that partner with contract labs must ensure they are following good lab practices and other quality assurance programs.
Feb 1, 2020 | Did You Know, EASeNews
Data Universal Number Systems, commonly known as DUNS are unique, site specific, nine-digit identification numbers provided by Dun & Bradstreet (D&B) and used globally. Free to obtain, FDA and other federal agencies use DUNS numbers to track and verify company...